Myopridin (Pridinol Mesilate)

Myopridin (pridinol mesilate) is employed to manage conditions characterized by increased skeletal muscle tone.

• Muscle spasm: alleviates involuntary muscle contraction and associated discomfort.
• Acute musculoskeletal pain: reduces pain resulting from sudden strain or injury.
• Back pain: relaxes paraspinal muscles to improve movement and lessen pain.
• Skeletal muscle disorders: helps normalize muscle tone and enhance functional comfort.

• Pridinol mesilate exerts its effect by acting centrally as an anticholinergic agent. It blocks muscarinic receptors in the brainstem, diminishing cholinergic neurotransmission that contributes to muscle tone. This reduction in central cholinergic activity leads to a decrease in skeletal muscle hypertonicity, producing muscle relaxation without directly affecting the peripheral neuromuscular junction. The drug does not possess significant analgesic properties, so its clinical benefit derives primarily from the relaxation of overactive muscles.

Pridinol mesilate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Dry mouth: reduced salivation leading to throat discomfort.
• Drowsiness: increased sleepiness or fatigue.
• Dizziness: sensation of light‑headedness or imbalance.
• Nausea: mild stomach upset.
• Blurred vision: temporary visual disturbances.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Hepatic dysfunction: elevated liver enzymes or jaundice.
• Cardiac arrhythmia: irregular heart rhythm.
• Profound hypotension: marked drop in blood pressure.
• Psychotic symptoms: hallucinations or severe confusion.

When prescribing Myopridin, clinicians should consider several precautionary measures to ensure safe use.

• Assess renal and hepatic function: evaluate organ status before initiating therapy.
• Monitor anticholinergic load: avoid excessive cumulative anticholinergic effects.
• Caution in glaucoma patients: anticholinergic activity may increase intra‑ocular pressure.
• Use carefully in the elderly: heightened risk of sedation and falls.
• Avoid concurrent CNS depressants: limit additive sedative effects.
• Store at ambient temperature: keep tablets in the original container, protect from moisture and direct sunlight.

Pridinol mesilate can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Other anticholinergic agents: may intensify anticholinergic side effects.
• Central nervous system depressants (e.g., benzodiazepines, opioids): increase sedation and respiratory depression risk.
• Antihistamines with strong anticholinergic properties: compound dry mouth and blurred vision.

Moderate Interactions (Monitor Closely)

• Alcohol: can enhance drowsiness and dizziness.
• Antihypertensive drugs: may potentiate blood pressure lowering effects.
• CYP450 inhibitors: may affect metabolism and increase plasma concentrations.